• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Moving the Bar on Chronic Obstructive Pulmonary Disease Readmissions before and after the Hospital Readmission Reduction Program: Myth or Reality?

作者信息

Rinne Seppo T, Press Valerie G

机构信息

Center for Healthcare Organization and Implementation Research, U.S. Department of Veterans Affairs, Bedford, Massachusetts.

The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts; and.

出版信息

Ann Am Thorac Soc. 2020 Apr;17(4):423-425. doi: 10.1513/AnnalsATS.202001-010ED.

DOI:10.1513/AnnalsATS.202001-010ED
PMID:32233856
Abstract
摘要

相似文献

1
Moving the Bar on Chronic Obstructive Pulmonary Disease Readmissions before and after the Hospital Readmission Reduction Program: Myth or Reality?在医院再入院减少计划实施前后推动慢性阻塞性肺疾病再入院率的变化：神话还是现实？
Ann Am Thorac Soc. 2020 Apr;17(4):423-425. doi: 10.1513/AnnalsATS.202001-010ED.
2
Time to Revisit the Hospital Readmissions Reduction Program for Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbations.是时候重新审视慢性阻塞性肺疾病急性加重住院患者的医院再入院减少计划了。
Am J Respir Crit Care Med. 2021 Feb 15;203(4):403-404. doi: 10.1164/rccm.202009-3392ED.
3
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.2009 年至 2014 年佛罗里达州慢性阻塞性肺疾病（COPD）患者再入院率、住院费用和死亡率趋势。
Clin Ther. 2018 Apr;40(4):613-626.e1. doi: 10.1016/j.clinthera.2018.03.006. Epub 2018 Mar 31.
4
Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates.慢性阻塞性肺疾病急性加重：社会因素对住院时间和再入院率的影响
Can Respir J. 2008 Oct;15(7):361-4. doi: 10.1155/2008/569496.
5
Exploring Novel Medicare Readmission Risk Variables in Chronic Obstructive Pulmonary Disease Patients at High Risk of Readmission within 30 Days of Hospital Discharge.探索慢性阻塞性肺疾病患者中 30 天内再入院高风险患者的新型医疗保险再入院风险变量。
Ann Am Thorac Soc. 2015 Sep;12(9):1288-93. doi: 10.1513/AnnalsATS.201504-228OC.
6
Association Between Financial Incentives in Medicare's Hospital Readmissions Reduction Program and Hospital Readmission Performance.医疗保险医院再入院率降低计划中的经济激励与医院再入院绩效之间的关联。
JAMA Netw Open. 2020 Apr 1;3(4):e202044. doi: 10.1001/jamanetworkopen.2020.2044.
7
Differential Risk Factors for Chronic Obstructive Pulmonary Disease 30-Day Readmissions According to Indication for Readmission.根据再入院指征分析慢性阻塞性肺疾病30天再入院的差异风险因素。
Ann Am Thorac Soc. 2016 Mar;13(3):447. doi: 10.1513/AnnalsATS.201512-813LE.
8
Evaluation of prediction strategy and care coordination for COPD readmissions.慢性阻塞性肺疾病再入院的预测策略与护理协调评估
Hosp Pract (1995). 2016 Aug;44(3):123-8. doi: 10.1080/21548331.2016.1210472. Epub 2016 Jul 19.
9
Smoke-Free Policies and 30-Day Readmission Rates for Chronic Obstructive Pulmonary Disease.无烟政策与慢性阻塞性肺疾病 30 天再入院率。
Am J Prev Med. 2019 Nov;57(5):621-628. doi: 10.1016/j.amepre.2019.06.008. Epub 2019 Sep 27.
10
Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates.慢性阻塞性肺疾病（COPD）综合病例管理项目对住院时间和再入院率的影响。
Int J Chron Obstruct Pulmon Dis. 2017 Mar 21;12:961-971. doi: 10.2147/COPD.S124385. eCollection 2017.

引用本文的文献

1
Effectiveness of a Bundled Payments for Care Improvement Program for Chronic Obstructive Pulmonary Disease.基于按病种付费的慢性阻塞性肺疾病医疗照护改善计划的效果。
J Gen Intern Med. 2023 Sep;38(12):2662-2670. doi: 10.1007/s11606-023-08249-6. Epub 2023 Jun 20.
2
Update in Chronic Obstructive Pulmonary Disease 2020.2020年慢性阻塞性肺疾病的最新进展
Am J Respir Crit Care Med. 2021 Jul 1;204(1):14-22. doi: 10.1164/rccm.202102-0253UP.
3
Preventing COPD Readmissions Under the Hospital Readmissions Reduction Program: How Far Have We Come?
在医院再入院率降低计划下预防 COPD 再入院：我们已经走了多远？
Chest. 2021 Mar;159(3):996-1006. doi: 10.1016/j.chest.2020.10.008. Epub 2020 Oct 14.